Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity

Open Access

Peer-reviewed

Research Article

Zania Stamataki ,

* E-mail: z.stamataki@bham.ac.uk

Affiliations Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom, National Institute for Health Research Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom
⨯
Samantha Tilakaratne,

Affiliation Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom
⨯
David H. Adams,

Affiliations Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom, National Institute for Health Research Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom
⨯
Jane A. McKeating

Affiliation Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom
⨯

Reader Comments (0)

B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
NK cells
Is the Subject Area "NK cells" applicable to this article?

Thanks for your feedback.
Cell degranulation
Is the Subject Area "Cell degranulation" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Viral replication
Is the Subject Area "Viral replication" applicable to this article?

Thanks for your feedback.